
Single cell-based drug discovery with Greg Ryslik (Celsius Therapeutics)
The Data Pulse
00:00
Is Single-Sulgenomics a New Drug Target?
The amount of potential things that can be addressed is vast. Over the last decade, you've already seen how drastically DNA sequencing has made some diseases that were previously terminal allow these patients a much greater quality of life. I strongly believe that single cell RNA sequencing is going to help us better understand the cellular molecular pathway changes that occur in diseases. It's going to provide us increased resolution where we didn't have it. And what we're going to be able to do is make new precision medicines that previously did not exist.
Play episode from 16:24
Transcript


